Rocket Lab (RKLB 6.79%) stock is soaring higher Wednesday. The company's share price was up 6.8% as of 1:45 p.m.
RKLB has corrected 33% since my original analysis, now trading at $18.73 within my fair value range of $16-18, offering a more balanced risk-reward profile. Q4 revenues surged 121% year-over-year to $132.4M, with Space Systems now contributing 65% of revenue, while gross margins improved to 34%. Despite promising growth, operating losses of $51.5M and continued R&D investment in Neutron highlight the long path to profitability.
Rocket Lab USA, Inc. (NASDAQ:RKLB ) KeyBanc Emerging Technology Summit March 4, 2025 8:00 PM ET Company Participants Adam Spice - CFO Conference Call Participants Michael Leshock - KeyBanc Capital Markets Michael Leshock So much for being here. My name is Mike Leshock, and I cover aerospace and defense at KeyBanc with a focus on Space Technologies.
Rocket Lab USA's (RKLB 1.80%) quarterly financials matched Wall Street expectations, but the company's guidance failed to quell the worries surrounding the stock.
After soaring higher in 2024, shares of Rocket Lab USA (RKLB -3.75%) haven't enjoyed the same upward trajectory so far in 2025. For those who have hopped aboard for a ride with the space stock, this year's poor performance -- a 26% plunge -- is surely disconcerting as the S&P 500 index has remained about flat.
Rocket Lab USA Inc. NASDAQ: RKLB has recently experienced a sharp drop from its 52-week highs, leaving current investors wondering whether this selloff presents a buying opportunity or signals more downside ahead. After a year of massive triple-digit gains, the stock's sudden reversal has sparked speculation about what comes next for this space industry contender.
Rocket Lab's Q4 results showed a revenue increase to $132.4 million, but Q1 guidance disappointed investors, leading to a stock price drop. Despite a stretched valuation, Rocket Lab's stock is now more attractive, trading below 12x 2026 sales, presenting a better entry point. The Neutron launch is delayed to the second half of 2025, with significant work remaining, posing risks to the timeline.
In this video, I will be talking about Rocket Lab (RKLB 3.33%) and why I'm buying the recent pullback. Watch the short video to learn more, consider subscribing, and click the special offer link below.
Rocket Lab is a standout in the space race, with record revenue growth, a $1B backlog, and a 100% launch success rate. Its focus is on innovation and government contracts. Despite its potential, RKLB faces risks like market volatility, reliance on government budgets, and competition. Its stock is highly volatile, making it unsuitable for conservative investors. I maintain a Buy rating for RKLB due to its disruptive potential, but caution is advised. For those comfortable with risk, it offers significant upside as the space industry expands.
Rocket Lab is poised for significant growth with 20+ launches in 2025, including the highly anticipated Neutron rocket, a cost-effective Falcon 9 competitor. Despite a 35% stock retracement, Street analysts maintain a buy rating with a $25.50 price target. The author anticipates a potential $40 stock price by year-end 2025. The Bleecker Street short report's claims are debunked; Rocket Lab's execution and demand for Neutron remain strong, with multiple contracts already secured.
Rocket Lab (RKLB 2.37%) stock got thrown for a loop Friday morning, first crashing more than 18% in response to a disappointing earnings report, then recovering as investors took time to digest the news. As of 11:30 a.m.
Rocket Lab shares tumbled in the wake of the company's fourth-quarter results Thursday, weighed down by weak outlook, although analyst firm KeyBanc Capital Markets believes the company's long-term growth prospects are still strong.